UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition

Nature communications, 2021-05, Vol.12 (1), p.2498-2498, Article 2498

2021

Volltextzugriff (PDF)

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells

Clinical cancer research, 2017-05, Vol.23 (9), p.2277-2288

2017

Volltextzugriff (PDF)

"Metastatic Cancer of Unknown Primary" or "Primary Metastatic Cancer"?

Frontiers in oncology, 2020-01, Vol.9, p.1546-1546

2020

Volltextzugriff (PDF)

MRI and intraoperative pathology to predict nipple–areola complex (NAC) involvement in patients undergoing NAC-sparing mastectomy

European journal of cancer (1990), 2015-09, Vol.51 (14), p.1882-1889

2015

Volltextzugriff (PDF)

Expression and Functional Regulation of Myoglobin in Epithelial Cancers

The American journal of pathology, 2009-07, Vol.175 (1), p.201-206

2009

Volltextzugriff (PDF)

Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary

EMBO molecular medicine, 2023-03, Vol.15 (3), p.e16104-n/a

2023

Volltextzugriff (PDF)

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST

International journal of molecular sciences, 2022-09, Vol.23 (18), p.10368

2022

Volltextzugriff (PDF)

Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer

Frontiers in oncology, 2020-02, Vol.10, p.173-173

2020

Volltextzugriff (PDF)

Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas

Cancer research (Chicago, Ill.), 2014, Vol.74 (1), p.119-129

2014

Volltextzugriff (PDF)

Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

Clinical cancer research, 2011-05, Vol.17 (10), p.3146-3156

2011

Volltextzugriff (PDF)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial

Biomedicines, 2020-04, Vol.8 (5), p.102

2020

Volltextzugriff (PDF)

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

EMBO molecular medicine, 2020-07, Vol.12 (7), p.e11756-n/a

2020

Volltextzugriff (PDF)

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

Journal of experimental & clinical cancer research, 2023-11, Vol.42 (1), p.1-310, Article 310

2023

Volltextzugriff (PDF)

Ab-Induced Ectodomain Shedding Mediates Hepatocyte Growth Factor Receptor down-Regulation and Hampers Biological Activity

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (13), p.5090-5095

2006

Volltextzugriff (PDF)

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy

Oncoimmunology, 2018-11, Vol.7 (11), p.e1465161-e1465161

2018

Volltextzugriff (PDF)

PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study

Cancers, 2021-12, Vol.13 (24), p.6295

2021

Volltextzugriff (PDF)

Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles

Cancers, 2020-06, Vol.12 (6), p.1495

2020

Volltextzugriff (PDF)

Genetic targeting of the kinase activity of the Met receptor in cancer cells

Proceedings of the National Academy of Sciences - PNAS, 2007-07, Vol.104 (27), p.11412-11417

2007

Volltextzugriff (PDF)

VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas

Melanoma research, 2005-02, Vol.15 (1), p.39-43

2005

Volltextzugriff (PDF)

Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

Clinical cancer research, 2012-05, Vol.18 (9), p.2515-2525

2012

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells

"Metastatic Cancer of Unknown Primary" or "Primary Metastatic Cancer"?

MRI and intraoperative pathology to predict nipple–areola complex (NAC) involvement in patients undergoing NAC-sparing mastectomy

Expression and Functional Regulation of Myoglobin in Epithelial Cancers

Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST

Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer

Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas

Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Oxaliplatin, Cisplatin, and Doxorubicin in Patients with Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

Ab-Induced Ectodomain Shedding Mediates Hepatocyte Growth Factor Receptor down-Regulation and Hampers Biological Activity

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy

PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study

Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts

Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles

Genetic targeting of the kinase activity of the Met receptor in cancer cells

VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization

Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

Aktive Filter

Suchergebnisse filtern